Table 2 Correlations between clinicopathological findings and Noggin or RBPMS2 protein expression in invasive front
From: Prognostic value of noggin protein expression in patients with resected gastric cancer
Variables | Noggin (invasive) | RBPMS2 (invasive) | ||||
|---|---|---|---|---|---|---|
Low (n = 73) | High (n = 90) | P-value | Low (n = 94) | High (n = 69) | P-value | |
Pathological T stage | Â | Â | 0.008 | Â | Â | 0.132 |
 T2/T3 | 30 (35.3) | 55 (64.7) |  | 45 (52.9) | 40 (47.1) |  |
 T4 | 43 (55.1) | 35 (44.9) |  | 49 (62.8) | 29 (37.2) |  |
Pathological N stage | Â | Â | 0.070 | Â | Â | 0.051 |
 N0 | 21 (36.2) | 37 (63.8) |  | 28 (48.3) | 30 (51.7) |  |
 N1-N3 | 52 (49.5) | 53 (50.5) |  | 66 (62.9) | 39 (37.1) |  |
Lauren’s classification |  |  | <  0.001 |  |  | <  0.001 |
 Intestinal type | 24 (30.8) | 54 (69.2) |  | 32 (41.0) | 46 (59.0) |  |
 Non-intestinal typea | 49 (57.6) | 36 (42.4) |  | 62 (72.9) | 23 (27.1) |  |
Lymphatic invasion | Â | Â | 0.185 | Â | Â | 0.013 |
 No | 21 (38.9) | 33 (61.1) |  | 24 (44.4) | 30 (56.6) |  |
 Yes | 52 (47.7) | 57 (52.3) |  | 70 (64.2) | 39 (35.8) |  |
Vascular invasion | Â | Â | 0.505 | Â | Â | 0.287 |
 No | 60 (44.4) | 75 (55.6) |  | 76 (56.3) | 59 (43.7) |  |
 Yes | 13 (46.4) | 15 (53.6) |  | 18 (64.3) | 10 (35.7) |  |
EBV positivity | Â | Â | 0.250 | Â | Â | 0.425 |
 No | 67 (43.8) | 86 (56.2) |  | 89 (58.2) | 64 (41.8) |  |
 Yes | 6 (60.0) | (40.0) |  | 5 (50.0) | 5 (50.0) |  |
Peritoneal seeding | Â | Â | 0.234 | Â | Â | 0.141 |
 Negative | 63 (43.4) | 82 (56.6) |  | 81 (55.9) | 64 (44.1) |  |
 Positive | 10 (55.6) | 8 (44.4) |  | 13 (72.2) | 5 (27.8) |  |